SINCE LAST ISSUE…

What’s happened since the last issue of Cannabis & Tech Today?

Kentucky joined America’s growing list of pro-cannabis states when it legalized medical use in March. Patients will not be permitted to smoke cannabis and must have a qualifying medical condition such as cancer, epilepsy, multiple sclerosis, or PTSD.

In April, the U.S. House of Representatives narrowly approved the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act. The bill would decriminalize cannabis at the federal level by removing it from the Drug Enforcement Agency’s list of Schedule I substances. It would also expunge criminal records for those with certain cannabisrelated offenses and reduce sentences for others. The MORE Act will now move on to the U.S. Senate for consideration.

While America is making strides toward legalization, the global cannabis community suffered a significant loss with the passing of Raphael Mechoulam in March. He was the first to isolate the psychoactive compound of cannabis (tetrahydrocannabinol, or THC). His decades of groundbreaking research helped the global community understand the plant’s medical and scientific value. In 1992, he published a study pinpointing the earliest evidence of cannabis use, dated to a Roman tomb in the 4th century. Mechoulam was 92 at the time of his death.

To stay up-to-date on all things cannabis, join the Concentrated Cannatech newsletter at cannatechtoday.com and receive the latest news straight to your inbox.

SPECIAL THANKS TO: Morris Beegle, Elizabeth Lunt, Cheryl Miller, Sean Dolan, NORML, Adam Farrell, Adam Moritz, Byron Ligon, Connie Hunt

This publication is dedicated to the dreamers, the innovators, the collaborators, and the doers – who can’t be bothered by those saying it can’t be done. Nicholas and Aria, the future is yours!